新着Pick
2Picks
Pick に失敗しました

人気 Picker
モデルナのリリースはこちら。
https://bit.ly/3nSw8Gg
「Initial analysis of Phase 2/3 TeenCOVE study of mRNA-1273 in adolescents ages 12 to 17 years showed vaccine efficacy against COVID-19 of 96%; mRNA-1273 was generally well tolerated with no serious safety concerns identified to date」